During the past decade, TPMG Clinical Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "TPMG Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "TPMG Clinical Research" are "Atrial Fibrillation" (1 trials), "COVID-19" (1 trials), "Cardiovascular Disease" (1 trials), "Chlamydia" (1 trials) and "End Stage Renal Disease" (1 trials). Many other conditions were trialed in "TPMG Clinical Research" in a lesser frequency.

Most popular intervention types in "TPMG Clinical Research" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "EVO100" (1 trials), "Methotrexate" (1 trials), "PF-07321332" (1 trials) and "Ritonavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "TPMG Clinical Research" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "TPMG Clinical Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in TPMG Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in TPMG Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".